Clinical Trial Update: Efficacy and Safety of Recombinant Asparaginase in Infants With Previously Untreated Acute Lymphoid Leukemia (ALL) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of recombinant asparaginase in infants with previously untreated acute lymphoblastic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• recombinant asparaginase (asparaginase)

Snippet

Sponsor: medac GmbH | Conditions: Acute Lymphoid Leukemia | Phase 2 | Status: COMPLETED